2.22 (-%)
As of Nov 20, 2024
Source:
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.
| Country | United States |
| Headquarters | cambridge, massachusetts |
| Phone Number | (617) 498-0020 |
| Industry | manufacturing |
| CEO | Martin Huber |
| Website | www.mersana.com |